Sign up to save your podcasts
Or
Share Harnessing data science and technology to uncover innovations
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Harnessing data science and technology to uncover innovations
How advanced #technologies can unlock the #potential of the life sciences industry?
By integrating #technologies into #research workflows, businesses in the #scientific and #healthcare fields can offer significant #value.
Indeed, attention today is on how to utmost #opportunities to deliver value by incorporating IT/#Tech approaches into #scientific process actions. In this #podcast episode, we highlight with our guest Liesbeth Ceelen how bio/pharma companies can benefit from AI-driven discoveries (and not only) and why it is time for focusing on Tech #investments.
Some of the most exciting #breakthroughs in #medicine today are happening at the nexus of #biology and #computer science, using tools such as artificial #intelligence (AI), machine learning (#ML) or #data science. Advanced #technologies specifically adapted for #sciences help in growing #healthcare #innovations at unprecedented scales and will build comprehensive predictive models that could span various subdisciplines.
The ability to store and analyze #data with the help of #AI has created new #possibilities for the academic community, #scientific researchers and the #biotech industry. Various applications of #AI are used in #biology. Moreover, in #biological science, AI plays a critical role in promoting innovation not only in laboratories but also throughout the #lifecycle of a #medication or #chemical product.
Furthermore, the extensive use of #bigdata is becoming increasingly important in #biotechnology and #bioinformatics as it continues to evolve and becomes available to academicians and #scientists.
Besides, a new generation of diverse #scientists must be trained at the intersection of biology and computer science (such as #Datascientists) and #training must be addressed in a more cross-disciplinary manner.
Liesbeth Ceelen holds a #PhD in #veterinary #medicine. She has been working in #start-up / scale-up companies in the #biotech and #healthcare fields where she took on numerous roles. Liesbeth is now #CEO of BioLizard, an #agile #bioinformatics and #datamanagement #consulting company providing tailored solutions to the life #sciences industry. She has both the scientific background and the management skills to lead #biotech businesses with vision and strategy. She aims in inspriring #people.
www.digitalcity.brussels
You can follow Liesbeth on LinkedIn or discover one of her project & success story
View all episodes
How advanced #technologies can unlock the #potential of the life sciences industry?
By integrating #technologies into #research workflows, businesses in the #scientific and #healthcare fields can offer significant #value.
Indeed, attention today is on how to utmost #opportunities to deliver value by incorporating IT/#Tech approaches into #scientific process actions. In this #podcast episode, we highlight with our guest Liesbeth Ceelen how bio/pharma companies can benefit from AI-driven discoveries (and not only) and why it is time for focusing on Tech #investments.
Some of the most exciting #breakthroughs in #medicine today are happening at the nexus of #biology and #computer science, using tools such as artificial #intelligence (AI), machine learning (#ML) or #data science. Advanced #technologies specifically adapted for #sciences help in growing #healthcare #innovations at unprecedented scales and will build comprehensive predictive models that could span various subdisciplines.
The ability to store and analyze #data with the help of #AI has created new #possibilities for the academic community, #scientific researchers and the #biotech industry. Various applications of #AI are used in #biology. Moreover, in #biological science, AI plays a critical role in promoting innovation not only in laboratories but also throughout the #lifecycle of a #medication or #chemical product.
Furthermore, the extensive use of #bigdata is becoming increasingly important in #biotechnology and #bioinformatics as it continues to evolve and becomes available to academicians and #scientists.
Besides, a new generation of diverse #scientists must be trained at the intersection of biology and computer science (such as #Datascientists) and #training must be addressed in a more cross-disciplinary manner.
Liesbeth Ceelen holds a #PhD in #veterinary #medicine. She has been working in #start-up / scale-up companies in the #biotech and #healthcare fields where she took on numerous roles. Liesbeth is now #CEO of BioLizard, an #agile #bioinformatics and #datamanagement #consulting company providing tailored solutions to the life #sciences industry. She has both the scientific background and the management skills to lead #biotech businesses with vision and strategy. She aims in inspriring #people.
www.digitalcity.brussels
You can follow Liesbeth on LinkedIn or discover one of her project & success story